Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study.
Guerrero-Zotano Á, Pérez-García JM, Ruiz-Borrego M, Bermejo B, Gil-Gil M, de la Haba J, Alba Conejo E, Quiroga V, Carañana V, Urruticoechea A, Morales S, Bellet M, Antón A, Fernández-Abad M, Sánchez-Rovira P, Calabuig L, Pérez-Escuredo J, Sampayo-Cordero M, Cortés J, Llombart-Cussac A.
Guerrero-Zotano Á, et al. Among authors: anton a.
ESMO Open. 2024 Sep 30;9(10):103733. doi: 10.1016/j.esmoop.2024.103733. Online ahead of print.
ESMO Open. 2024.
PMID: 39353215
Free PMC article.